NuCana (NCNA) Free Cash Flow (2017 - 2025)
NuCana (NCNA) reported Free Cash Flow of -$1.5 million for Q4 2025, up 84.01% on a YoY basis from -$831303.6 in Q4 2024, and down 188.7% sequentially from $1.7 million in Q3 2025.
NuCana (NCNA) Free Cash Flow (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Free Cash Flow data on file, last reported at -$1.5 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 84.01% year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2025 stood at $194793.7 (up 100.8% YoY), and the FY2025 full-year result was -$9.8 million, up 59.7% from the prior year.
- Free Cash Flow fell to -$1.5 million in Q4 2025, from $1.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.7 million in Q3 2025 to a low of -$27.1 million in Q4 2021.
- A 5-year average of -$7.8 million and a median of -$7.4 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 238.45% in 2022 and tumbled 8968.64% in 2024, its largest moves.
- Tracing NCNA's Free Cash Flow over 5 years: stood at -$27.1 million in 2021, then surged by 39.33% to -$16.4 million in 2022, then soared by 99.36% to -$105497.9 in 2023, then plunged by 8968.64% to -$9.6 million in 2024, then surged by 84.01% to -$1.5 million in 2025.
- Business Quant data shows NCNA's Free Cash Flow at -$1.5 million in Q4 2025, $1.7 million in Q3 2025, and -$9.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 48.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Sep 30, 2024 | -5.98 Mn |
| Sep 30, 2024 | -5.98 Mn |
| Jun 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -1.49 Mn |
| Mar 31, 2024 | -7.46 Mn |
| Mar 31, 2024 | -7.46 Mn |
| Dec 31, 2023 | -105,497.91 |
| Dec 31, 2023 | -105,497.91 |
| Sep 30, 2023 | -12.89 Mn |
| Sep 30, 2023 | -12.89 Mn |
| Jun 30, 2023 | -7.32 Mn |
| Jun 30, 2023 | -7.32 Mn |
| Mar 31, 2023 | -12.56 Mn |
| Mar 31, 2023 | -12.56 Mn |